DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 157 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $922,518 | -4.5% | 72,525 | +5.7% | 0.00% | – |
Q2 2023 | $966,001 | -53.4% | 68,608 | -48.8% | 0.00% | – |
Q1 2023 | $2,071,119 | -2.2% | 134,053 | +3.8% | 0.00% | – |
Q4 2022 | $2,117,342 | -34.2% | 129,185 | -25.8% | 0.00% | – |
Q3 2022 | $3,219,000 | +67.8% | 174,003 | +19.3% | 0.00% | – |
Q2 2022 | $1,918,000 | -18.9% | 145,852 | -42.9% | 0.00% | – |
Q1 2022 | $2,365,000 | -85.1% | 255,216 | -84.2% | 0.00% | – |
Q4 2021 | $15,820,000 | +226.1% | 1,619,354 | +1033.9% | 0.00% | – |
Q3 2021 | $4,852,000 | -21.1% | 142,815 | -15.0% | 0.00% | – |
Q2 2021 | $6,150,000 | +17.5% | 167,999 | +43.9% | 0.00% | – |
Q1 2021 | $5,234,000 | -78.9% | 116,730 | -73.1% | 0.00% | -100.0% |
Q4 2020 | $24,794,000 | +89.7% | 434,454 | +70.5% | 0.00% | -66.7% |
Q3 2020 | $13,069,000 | -1.2% | 254,777 | +15.0% | 0.00% | 0.0% |
Q2 2020 | $13,231,000 | +107.5% | 221,545 | +43.0% | 0.00% | +50.0% |
Q1 2020 | $6,377,000 | -71.7% | 154,886 | -57.2% | 0.00% | -66.7% |
Q4 2019 | $22,535,000 | +162.3% | 362,051 | +43.0% | 0.01% | +100.0% |
Q3 2019 | $8,591,000 | +135.2% | 253,117 | +56.3% | 0.00% | – |
Q2 2019 | $3,652,000 | +1402.9% | 161,892 | +1295.6% | 0.00% | – |
Q4 2018 | $243,000 | -23.6% | 11,600 | +41.5% | 0.00% | – |
Q3 2018 | $318,000 | -10.2% | 8,200 | -8.9% | 0.00% | – |
Q2 2018 | $354,000 | – | 9,001 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 1,209,571 | $11,213,000 | 5.53% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,580,456 | $51,731,000 | 1.16% |
ARMISTICE CAPITAL, LLC | 5,836,000 | $54,100,000 | 1.05% |
Pinz Capital Management, LP | 165,835 | $1,537,000 | 0.96% |
Sunesis Advisors, LLC | 96,299 | $893,000 | 0.52% |
Redmile Group, LLC | 664,817 | $6,163,000 | 0.19% |
PDT Partners, LLC | 222,343 | $2,061,000 | 0.18% |
Bayesian Capital Management, LP | 41,900 | $388,000 | 0.06% |
Laurion Capital Management LP | 459,290 | $4,258,000 | 0.05% |
Hennion & Walsh Asset Management, Inc. | 101,643 | $942,000 | 0.05% |